Feng Zhu

Feng Zhu

Auto-generated profile, based on publicly available information

Feng Zhu

Department of General Surgery, Jinling Hospital, Nanjing Medical University, Nanjing, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Digestive and Liver Disease
Verified
Journal Article
Closed access
FZFeng Zhu
Feng Zhu
CLChuling Li
Chuling Li
JGJianfeng Gong
Jianfeng Gong
WZWeiming Zhu
Weiming Zhu
LGLili Gu
Lili Gu
NLNing Li
Ning Li

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YZYangheng Zhang
Yangheng Zhang
DQDan Qiao
Dan Qiao
RCRixin Chen
Rixin Chen
FZFeng Zhu
Feng Zhu
JGJianfeng Gong
Jianfeng Gong
FYFuhua Yan
Fuhua Yan
Background. It has been reported that patients with inflammatory bowel disease (IBD) are more susceptible to periodontitis. However, data regarding the risk of periodontitis in IBD patients are scarce, and results from individual studies remain controversial. The aim of this study is to investigate the risk of periodontitis in IBD patients. Methods. Web of Science, PubMed, and Embase were searched for studies investigating the risk of periodontitis in the IBD patient population from Jan. 2000 to Nov. 2020. Articles were included if they contained the number of people with IBD diagnosed with periodontitis (or periodontal disease parameters) compared with a control group. Case reports, reviews, animal studies, and articles without available abstracts were excluded. A pooled odds ratio (OR) and 95% confidence interval (CI) were calculated to assess the association between periodontitis and IBD. Results. Six studies were included in the meta‐analysis. The overall risk of periodontitis was significantly higher in IBD patients than controls (OR: 2.10, 95% CI: 1.60‐2.74; I2 = 27%). In particular, Crohn’s disease (CD) and ulcerative colitis (UC) were both linked to an increased risk of periodontitis (OR: 1.72, 95% CI: 1.36‐2.19; I2 = 0% for CD vs. OR:2.39, 95% CI: 1.19‐4.80; I2 = 85% for UC). Conclusions. IBD patients are at higher risk of periodontitis than controls. After subgroup analysis, the elevated risk remained significant when analyzing CD or UC alone. UC patients were at higher risk of developing periodontitis than CD patients.

7 March 2023 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
TXTingbin Xie
Tingbin Xie
TLTengfei Lv
Tengfei Lv
TZTenghui Zhang
Tenghui Zhang
DFDengyu Feng
Dengyu Feng
FZFeng Zhu
Feng Zhu
JGJianfeng Gong
Jianfeng Gong
Background: Inflammatory cytokine interleukin‐6 (IL‐6) plays a pivotal role in skeletal muscle degradation after intra‐abdominal sepsis (IAS), with mechanism remained to be elucidated. Indoleamine 2,3‐dioxygenase 1 (IDO‐1), a key enzyme in converting tryptophan into kynurenine, could be activated by IL‐6, and kynurenine has been shown to be involved in muscle degradation. We hypothesized that IL‐6 could promote muscle degradation via tryptophan–IDO‐1–kynurenine pathway in IAS patients.Methods: Serum and rectus abdominis (RA) were obtained from IAS or non‐IAS patients. Mouse model of IAS‐induced muscle wasting was generated by caecal ligation and puncture (CLP) and lipopolysaccharide (LPS) injection. IL‐6 signalling was blocked by anti‐mouse IL‐6 antibody (IL‐6‐AB), and the IDO‐1 pathway was blocked by navoximod. To elucidate the role of kynurenine in muscle mass and physiology, kynurenine was administered to IAS mice treated with IL‐6‐AB.Results: Compared to non‐IAS patients, kynurenine levels in serum (+2.30‐fold vs. non‐IAS, P < 0.001) and RA (+3.11‐fold vs. non‐IAS, P < 0.001) were elevated, whereas tryptophan levels in serum (−53.65% vs. non‐IAS, P < 0.01) and RA (−61.39% vs. non‐IAS, P < 0.01) were decreased. Serum IL‐6 level of the IAS group was significantly higher compared to non‐IAS patients (+5.82‐fold vs. non‐IAS, P = 0.01), and muscle cross‐sectional area (MCSA) was markedly reduced compared to non‐IAS patients (−27.73% vs. non‐IAS, P < 0.01). In animal experiments, IDO‐1 expression was up‐regulated in the small intestine, colon and blood for CLP or LPS‐treated mice, and there was correlation (R2 = 0.66, P < 0.01) between serum and muscle kynurenine concentrations. Navoximod significantly mitigated IAS‐induced skeletal muscle loss according to MCSA analysis (+22.94% vs. CLP, P < 0.05; +23.71% vs. LPS, P < 0.01) and increased the phosphorylated AKT (+2.15‐fold vs. CLP, P < 0.01; +3.44‐fold vs. LPS, P < 0.01) and myosin heavy chain (+3.64‐fold vs. CLP, P < 0.01; +2.13‐fold vs. LPS, P < 0.01) protein expression in myocytes. In the presence of anti‐IL‐6 antibody, a significantly decreased IDO‐1 expression was observed in the small intestine, colon and blood in CLP or LPS mice (all P < 0.01), whereas the decrease of MCSA was alleviated (+37.43% vs. CLP + IgG, P < 0.001; +30.72% vs. LPS + IgG, P < 0.001). In contrast, additional supplementation of kynurenine decreased the MCSA in septic mice treated with IL‐6‐AB (both P < 0.01).Conclusions: This study provided novel insights into the tryptophan–IDO‐1–kynurenine‐dependent mechanisms that underlie inflammatory cytokine‐induced skeletal muscle catabolism during intra‐abdominal sepsis.

21 June 2018 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
FZFeng Zhu
Feng Zhu
DFDengyu Feng
Dengyu Feng
TZTenghui Zhang
Tenghui Zhang
LGLili Gu
Lili Gu
WZWeiming Zhu
Weiming Zhu
NLNing Li
Ning Li

15 May 2018 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
FZFeng Zhu
Feng Zhu
DFDengyu Feng
Dengyu Feng
TZTenghui Zhang
Tenghui Zhang
LGLili Gu
Lili Gu
WZWeiming Zhu
Weiming Zhu
JLJieshou Li
Jieshou Li

3 April 2018 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
YWYao Wei
Yao Wei
FZFeng Zhu
Feng Zhu
JGJianfeng Gong
Jianfeng Gong
JYJianbo Yang
Jianbo Yang
TZTenghui Zhang
Tenghui Zhang
JLJieshou Li
Jieshou Li
Aim. Excessive postoperative inflammatory response, which is characterized by overproduction of cytokines, often leads to complications after colorectal surgery. However, the impact of body composition on postoperative inflammatory response is largely unknown. The aim of this study is to elucidate whether body fat amount and its distribution affects postoperative inflammation after colorectal surgery in IBD patients. Methods. Eighty-six patients undergoing colorectal resection for IBD from June 2014 to Jan 2017 were enrolled. Abdominal CT images within one week prior to surgery were assessed for visceral fat, subcutaneous fat, and muscle mass. Postoperative inflammatory response was evaluated using serum CRP, PCT, and IL-6 levels on postoperative days 1, 3, and 5. Univariate analysis was conducted to identify risk factors for infectious complications. The correlation between body composition and postoperative plasma concentration of inflammatory markers was analyzed using a linear regression model. ROC curve was applied to analyze the effect of different body composition parameters on postoperative infectious complications and to determine the relationship between inflammatory markers and infectious complications. Results. Neither volume of fat or muscle was related to postoperative plasma concentrations of CRP, IL-6, and PCT. However, visceral to subcutaneous fat ratio was associated with PCT levels on postoperative days (POD) 1, 3, and 5, with the highest regression coefficient on POD1 (β=0.360; 95% CI, 0.089–0.631; P=0.010). Body composition did not predict postoperative infectious complications, while CRP on POD 3 was predictive of infectious complications. Conclusion. Increased visceral to subcutaneous fat ratio was associated with postoperative inflammatory response in IBD patients undergoing colorectal resection. This may partly explain the increased incidence of postoperative complications in patients with visceral obesity.